United Kingdom

Hisamitsu Pharmaceutical Co Inc (4530.T)

4530.T on Tokyo Stock Exchange

16 Aug 2019
Change (% chg)

¥25 (+0.59%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Hirotaka Nakatomi

81 2015 Chairman of the Board, Chief Executive Officer, Representative Director

Kazuhide Nakatomi

45 2015 President, Chief Operating Officer, Representative Director

Shinichiro Takao

63 2016 Executive Officer, Chief Director of BU, Director of Finance, Manager of IR Office, President of Subsidiary, Director

Naruhito Higo

55 2016 Chairman of Subsidiary, Director

Kosuke Sugiyama

66 2016 Senior Managing Director, Executive Officer